I think a lot about where a VC firm like CT Innovations plays in the larger venture ecosystem, as well as what types of deals are in our "sweet spot." The way I think about it now (which is sure to evolve over time) is that we are an agglomeration of many VC strategies all lumped under one umbrella. I'd like to think that most venture firms have one or two "founder archetypes" in its sweet spot -- but given our mandate of investing in nearly anything that comes out of the state, we have no singular archetype. The way I've come to think about it is a sort of mental accounting: many deals fit our portfolio, but some because with an economic/catalytic tilt and others because they are ones larger players (a16z, etc.) would be interested in.
From what I've seen thus far, some of the archetypes I've seen and diligenced:
- Industry specialist, great founder, great business, "small" TAM -- Right now, I think this is our sweet spot -- a great founder (often repeat founder) building great businesses in a $1-5B market, too small for other venture investors to get excited (i.e. no "homerun," unicorn upside) but a potential for a great return.
- High-growth potential unicorns -- Connecticut simply gets fewer of these high-growth, "hype" companies where valuations step up 2-5x between rounds. These are the a16z/Sequoia/Thrive archetypes -- super high growth potential, high valuations compared to revenue, "true" venture deals that can go 30x or 0x.
- Catalytic capital -- These deals have an "impact" angle to them. By no means are these deals meant to be concessionary, though. CT has a host of amazing talent -- Yale/UConn professors across science and tech, as well as pharma and insurance expertise -- that have the potential to become great companies. We can be one of the first checks in on these deals.
- Economic development -- Less often, we make deals in part for local economic development.
No comments:
Post a Comment